Diabetes Newsletter – October 2018

www.berkshirewestdiabetes.org.uk October 2018
Monthly diabetes news for healthcare professionals and
others in Berkshire West

  X-Pert Update  
Congratulations to Berkshire Healthcare NHS Foundation Trust (BHFT) and their X-Pert Educators on winning more awards at the recent national X-Pert Awards Ceremony. Their achievements were as follows:

1st Place
In the category “largest impact on body weight and waist circumference”.
Average 4kg weight loss and 2.7cm reduction in waist circumference.

2nd Place
In two categories:
  • “Greatest improvement in HbA1c” (14-16mmol/mol)
  • “Greatest improvement in cardiovascular risk factors” (BP and cholesterol ratios)
Reminder – Key Points about X-Pert:
  1. All newly diagnosed T2s should be encouraged to attend but please discuss with the patient at the point of referral.
  2. Open to T2s who are not newly diagnosed but have not attended patient education or would like a refresher.
  3. Variety of locations and times available across Berkshire West.
  4. Nationally accredited, award winning, evidence-based course.
  5. Run by trained educators with a diabetes background, e.g. dieticians and nurses.
  6. Referral form on DXS – send to the HUB.
  7. Six 2.5 hour sessions:
    Session 1: What is diabetes?
    Session 2: Healthy eating and weight management
    Session 3: Carbohydrate awareness
    Session 4: Reading food labels
    Session 5: Possible complications of diabetes
    Session 6: Summary and future planning
  8. Please ensure Practice Admin Teams code attendance or otherwise. Codes are available here.
  New American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) guidelines  
The American Diabetes Association and the European Association for the Study of Diabetes have updated their prior position statements, published in 2012 and 2015, on the management of type 2 diabetes in adults.

A systematic evaluation of the literature since 2014 informed new recommendations. These include:
  • Additional focus on lifestyle management and diabetes self-management education and support.
  • For those with obesity; Efforts targeting weight loss, including lifestyle, medication and surgical interventions are recommended.
  • With regards to medication management, for patients with clinical cardiovascular disease, a sodium–glucose cotransporter-2 (SGLT2) inhibitor or a glucagon-like peptide-1 (GLP-1) receptor agonist with proven cardiovascular benefit is recommended.
  • For patients with chronic kidney disease or clinical heart failure and atherosclerotic cardiovascular disease, an SGLT2 inhibitor with proven benefit is recommended. GLP-1 receptor agonists are generally recommended as the first injectable medication.
  Latest NDA collection and publication dates 2018-19  
The latest NDA collection and publication dates are available here.
Diabetes Specialist Nurse Hotline: 07879 814922 (Monday to Friday 10am – 4pm) Consultant Hotline: 07717 867448. Email: virtualdiabetes@royalberkshire.nhs.uk
Visit our website: www.berkshirewestdiabetes.org.uk
Click here to read online